Baker Julian's Form 4 filing
BeOne Medicines Ltd. (ONC) · filed May 27, 2026
- Accession no.
- 0001193125-26-242066
- Filed
- May 27, 2026, 4:54 PM ET
- Trade date
- May 22, 2026
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions. Open-market sales total $262.0K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Baker JulianCIK 0001087939 | Director |
| Baker FelixCIK 0001087940 | Director |
| Baker Bros. Advisors LPCIK 0001263508 | Director |
| Baker Brothers Life Sciences LPCIK 0001363364 | Director |
| 667, L.P.CIK 0001551139 | Director |
| Baker Bros. Advisors (GP) LLCCIK 0001580575 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 22, 2026 | Ordinary Shares | SSaleDisposed | −2,743 | $23.85 | −$65,423.84 | 145,322 | Indirect | |
| May 22, 2026 | Ordinary Shares | SSaleDisposed | −2,743 | $23.85 | −$65,423.84 | 145,326 | Indirect | |
| May 22, 2026 | Ordinary Shares | SSaleDisposed | −2,756 | $23.79 | −$65,566.62 | 142,566 | Indirect | |
| May 22, 2026 | Ordinary Shares | SSaleDisposed | −2,756 | $23.79 | −$65,566.62 | 142,570 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
On May 27, 2025, BeiGene, Ltd. consummated redomiciliation transactions from the Cayman Islands to Switzerland and a name change pursuant to which BeOne Medicines Ltd. (the "Issuer") became the successor issuer to BeiGene, Ltd. Michael Goller and Ranjeev Krishana, full-time employees of Baker Bros. Advisors LP, are directors of the Issuer. By virtue of their representation on the board of directors of the Issuer, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the reporting persons are deemed directors by deputization of the Issuer.